Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens.
Saved in:
| Title: | Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens. |
|---|---|
| Authors: | Rieger L; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Irlinger K; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Füchsl F; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Tietje M; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Purcarea A; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Barbian N; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Faber M; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Vogelsang C; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Pfeuffer L; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Institute of Laboratory Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany., Stotz S; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Karpiuk O; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Schulze T; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Augsburger A; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Glaisner N; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany., Konetzki V; Cellular Immunotherapy, University Hospital Würzburg, Würzburg, Germany.; Department of Medicine II, University Hospital Würzburg, Würzburg, Germany., Friedel S; Cellular Immunotherapy, University Hospital Würzburg, Würzburg, Germany.; Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.; Bavarian Cancer Research Center, Munich, Germany., Besse A; Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Besse L; Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Driessen C; Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Buchner M; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Institute of Laboratory Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany., Schwamborn K; Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany., Steiger K; Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung, Heidelberg, Germany.; Bavarian Cancer Research Center, Munich, Germany., Giansanti P; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Bavarian Center for Biomolecular Mass Spectrometry, School of Medicine and Health, Technical University of Munich, Munich, Germany., Theurich S; Bavarian Cancer Research Center, Munich, Germany.; Department of Medicine III, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Waldschmidt J; Department of Medicine II, University Hospital Würzburg, Würzburg, Germany., Kortüm KM; Department of Medicine II, University Hospital Würzburg, Würzburg, Germany., Hudecek M; Cellular Immunotherapy, University Hospital Würzburg, Würzburg, Germany.; Department of Medicine II, University Hospital Würzburg, Würzburg, Germany., Einsele H; Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.; Bavarian Cancer Research Center, Munich, Germany., Högner M; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany., Kuster B; Deutsches Konsortium für Translationale Krebsforschung, Heidelberg, Germany.; Bavarian Center for Biomolecular Mass Spectrometry, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany., Krackhardt AM; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung, Heidelberg, Germany.; Malteser Krankenhaus St. Franziskus-Hospital, Flensburg, Germany., Hecker JS; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Bavarian Cancer Research Center, Munich, Germany., Bassermann F; Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung, Heidelberg, Germany.; Bavarian Cancer Research Center, Munich, Germany. |
| Source: | Blood [Blood] 2026 Jan 29; Vol. 147 (5), pp. 534-546. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
